Chinese biotech firm Zenitar files for HK IPO after $86m Series C financing

Chinese biotech firm Zenitar files for HK IPO after $86m Series C financing

Photo from Zenitar

19 January, 2026

Edited by: Joymitra Rai

biotech Chengdu Zenitar Biomedical Technology first-in-class hong kong Qiming Venture Partners true light capital

Printed by Unregistered user on Thu, 12 Feb 2026 14:15:07 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Qiming-backed biotech Oricell raises $70m Series C1 round

Temasek's ClavystBio bets on AI to generate 2-3x returns from biotech

Read more from Greater China

Talent crunch tests Chinese banks amid Hong Kong IPO boom

US men’s lifestyle brand Playboy to sell 50% of its China business to UTG